An Optimized Surfactant-Based PEG-PLCL in Situ Gel Formulation for Enhanced Activity of Rosuvastatin in Poloxamer-Induced Hyperlipidemic Rats
Drug Design, Development and Therapy - New Zealand
doi 10.2147/dddt.s224442
Full Text
Open PDFAbstract
Available in full text
Date
December 1, 2019
Authors
Publisher
Informa UK Limited